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Article 3

A Linacre Institute Paper
Rape Protocol
by
Eugene F. Diamond, M.D.

The occurrence of forcible rape is an event which appropriately calls forth an
intense emotional climate of condemnation for the perpetrator and sympathy for
the victim.) There has been a salutary change in the attitudes of society toward
this crime of violence, including well-organized measures to improve the
aftercare of the rape victim. Most states have statutes which require hospitals to
establish written protocols for the care of rape victims particularly in emergency
room settings. This has created conflicts for Catholic institutions with regard to
the recommendation for the use of so-called "morning-after" pill in rape
protocols. 2 The conflict relates to the action of hormones (large doses of estrogen
or estrogen-progestogen combinations) given during the post-rape period and the
intentionality of the health care provider in dispensing the hormones or referring
to agencies which will provide them. The crux of the matter is whether the
"morning-after" pill is an abortifacient through its effect in preventing
implantation or whether it can be a contraceptive through an effect of preventing
ovulation when given early in the cycle.
Contraception FoUowing Rape

The essentially immoral character of contraception is its "failure to preserve
the full sense of mutual self-giving and human procreation" (Gaudium et. spes
51). The wrongfulness of contraception has to do with a decision to bring oneself
into sexual union with another person and another decision positively to preclude
the transmission of new life (Familiaris Consortrio 32). The woman who has
been raped has not made the free choice of sexual union, and she is, therefore, free
to attempt to neutralize the effects of the assault which violated her bodily
integrity. In a practical sense, this might involve attempts to prevent sperm
transport or sperm capacitation or to suppress ovulation.
Abortifacient Effects

"Morning-after" pills given to a woman who has already conceived as a result
of forcible rape will alter the tubal transport of the zygote and will interfere with
the implantation of the blastocyst. 3 The prevention of implantation is an
abortifacient effect, and abortion is no less immoral and repugnant when it occurs
8
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in the earliest stages of intrauterine development. There have been attempts to
redefine "contraception" to include the prevention of implantation by declaring
the stages between fertilization and implantation to be "pre-embryonic". The
American College of Obstetrics and Gynecology defines pregnancy as beginning
with implantation, but this manipulation of language is not related to modem
scientific understanding so much as the need to fulfill a political agenda.
During the period between fertilization and implantation, the embryo
independently controls a sequence of events which are critical to its survival. The
single-cell zygote divides and differentiates into a cluster of cells. The outer layer
of cells secretes chorionic gonadotropin and develops the capacity to adhere and
invade the endometrial lining. Drugs which interfere with these stages of human
development are abortifacients, not contraceptives.
Postcoital Contraception

A statement approved by the British Bishops4 attempts to refine the issue by
distinguishing the effects of estrogen or estrogen-progestogen combinations
depending on the stage in the menstrual cycle at which they are administered.
The statement distinguishes three stages:
1) If administered prior to ovulation, the effect would be to prevent ovulation
and thereby fertilization by producing an anovulatory cycle.
2) If administered just before ovulation, high doses of hormone may prevent
conception by a) immobilizing sperm in the genital tract, b) by preventing
capacitation ofthe sperm, or c) affecting the cells surrounding the ovum
during the ovum's own preparation.
3) If administered after ovulation, the effect, if any, will be abortifacient
through a) alteration in the environment of the fallopian tube, b) inhibition
of implantation by the creation of a hostile environment in the
endometrium and, c) hormonal effects producing shedding of the
endometrium and loss of the implanting embryo.
The statement proposes that hormonal postcoital treatment be approved after
insemination by sexual assault provided· 1) There are no grounds for jUdging that
ovulation preceded or will coincide with the administration of hormones and 2)
The postcoital hormone is administered during the first 24-hours after rape.
The statement must be critically examined from two standpoints: 1) whether
or not the effects of hormones are truly as stated during the three stages of the
menstrual cycle and 2) whether or not the possibility of ovulation can be excluded
by history given the real-life circumstances of the aftercare of the rape victim .
.~

Suppression of Ovulation Early in the Cycle

~

The usual measure employed for postcoital contraception is 100 mcg. of
Ovral (an estrogen-progestogen combination) followed 12 hours later by a
second 100 mcg. dose of Ovral. Since Ovral is manufactured by Wyeth-Ayerst
Pharmaceuticals, an inquiry was submitted to the company regarding evidence

~
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that Ovral does, in fact, act as an anti-ovulant in the aforementioned dosage
schedule. The company provided referencess,6,7,8,9 regarding the use of d 1norgestrel and ethinyl estradiol (the hormonal components of Ovral) as a
postcoital contraceptive.
From the experimental data provided by the manufacturer, it can be inferred
that the scientific evidence to support the suppression of ovulation by two 100
mcg. doses of Ovral twelve hours apart is meager and inconclusive. The company
does not, in fact, claim such an effect. One recent publication 10 suggests that
RU-486 may disrupt follicular maturation, but it is unlikely that the rape protocol
of a Catholic hospital would want to recommend this French abortion pill.
1. Effects on Sperm - Progestogen changes the quality of the cervical
mucus to make penetration by spermatozoa more difficult. According to
experimental evidence observed by Klaus,11 however, sperm traverse the cervical
mucus at peak phase (time of ovulation) in a period of 90 seconds. Altering the
cervical mucus by Ovral given hours ,after the assault would not preclude free
access by sperm to the uterus.
2. Spenn Transport - Sperm transport time from the cervical os to the
oviduct has been variously estimated. 12, 13, 14 The best evidence is that this occurs in
minutes, possibly as soon as five minutes after intercourse. IS It is highly unlikely
that postcoital hormone therapy could cause immobilization of all or most of the
sperm in time to prevent their access to the tube and thereby fertilization.
3. Spenn Capacitation - Sperm Capacitation is the process by which the
sperm acquires the capability to cleave to and penetrate the ovum. Although this
usually occurs after a period of time in the female genital tract, it is also acquired
in the human outside the body such as in in-vitro fertilization. Ovral, which
contains progestogen can theoretically interfere with capacitation by impeding
the release of progesterone which is important in capacitation. Large doses of
Ovral could reduce sperm capacitation, but it is unlikely that it could prevent all
sperm capacitation prior to their migration and cleavage to the ovum. The
numbers of capacitated sperm reaching the ovum would be reduced to the extent
determined by the timing of hormone administration.
4. Tubal Motility - Large doses of estrogen reduce motility and ciliary
action in the oviduct. The timing of this effect in a post-rape situation indicates
that it would not interfere with sperm reaching the ovum so much as preventing
fertilized ova from moving back down the tube in proper phase for implantation.
The two most frequently quoted studies regarding the mechanisms of action of
"morning-after" pills are those of Blye 16 and Kuchera. 17 These authors stress the
following effects of postcoital agents:
a. Prevention of tubal transport of the zygote
b. Prevention of embryonic viability
c. Prevention of sperm transport
d. Loss of sperm viablity
e. Luteolysis
f. Prevention of implantation
As Blye states in his article, "it is somewhat rhetorical to include the effects on
male gametes here inasmuch as postcoital contraceptive therapy is contemplated
10
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long after spermatozoa have reached the site of fertilization in the female
reproductive tract." In summary, then, the logistics of the real life situation of the
aftercare of a rape victim are such that the only relevant effect of postcoital
hormonal agents is their ability to prevent implantation.
Menstrual History

A key factor in evaluating the use of "morning-after" pills under the guidelines
of the British Bishops' report is the woman's ability to provide reliable historical
evidence as to how an act of intercourse has been timed in her menstrual cycle. In
order to know whether it is licit to use Ovral, the attending physician should be
aware of whether the woman is pre-ovulatory, ovulating, or post-ovulatory. How
reliable is such historical evidence? A recent study published in the New England
Journal of Medicine 1s is of interest since all women in the study had laboratory
surveillance by way of plasma progesterone and urine pregnanediol levels. This
allowed objective laboratory confirmation of the women's subjective statements
about their cycles. Fifty-one percent of women who were believed to be in the
luteal phase by history had not ovulated. Twenty-one percent of women thought
to be pre-ovulatory, by their statements had, in fact, ovulated. The conclusion of
this objective hormone assay-controlled study was "most women do not keep
records of their menstrual periods and it is well-rocognized that estimated dates
are likely to be inaccurate': Given the uncertainty of information available at the
time of treatment, it is unlikely that the standard required by the British Bishops'
statement (i.e., "There are no grounds for judging that ovulation preceded or will
coincide with the administration of hormones") is achievable with any
acceptable degree of certitude.
Risk of Pregnancy After a Single Act of Forcible Rape

.~

."

Support for the use of postcoital agents is developed from studies done on
populations other than rape victims such as women on college campuses who
approach student health centers after an episode of "unprotected intercourse".
These studies compare the number of pregnancies following postcoital hormone
administration with the number expected following a single act of random
unprotected intercourse in any menstrual cycle. It has been noted 19 that many of
these studies have a methodological error, i.e., using the total number of women
in the study as the denominator rather than the number of women actually
potentially pregnant. Also using the Tietze20 estimate of the expected incidence of
pregnancy following a single act of random unprotected intercourse as 3% may
be unrealistically high as compared with that of Pearl (0.3%). However accurate
these studies are, however, there is question as to whether the statistics truly apply
to the situation of a single act of forcible rape.
In a prospective study of 4,000 rapes in Minnesota, no pregnancies were
reported. 22 In a retrospective study, the States Attorney of Cook County, Illinois,
including Chicago, reported no pregnancies during a nine-year period of
prosecutions for rape. Similar retrospective studies done by law enforcement
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agencies in Erie County, New York, and Cuyahoga County, Ohio, reported not a
single pregnancy following rape in prosecutions covering thirty years in New
York and ten years in Ohio.23 In a prospective study of 117 rapes, there were no
pregnancies among the 100 women who received no post-rape hormones. 24
While not all rapes are reported, there is no reason to think that pregnancy is
more common after unreported rape than it is after reported rape. Some recent
studies have helped to shed light on this lower-than-expected incidence of
pregnancy following forcible rape.
1. There is a high rate of sexual dysfunction related to sexual assault. Groth
and Burgess reported2S that 57% of 10 1 rapists had erective or ejaculatory
dysfunction.
2. Rape is defined legally as penetration with or without ejaculation. A series
of studies26 have reported the recovery of spermatozoa from only about half
of rape victims including even victims of gang rape.
3. About 70% of rape victims will be at reduced risk because they are on
contraceptives, are pregnant, post-menopausal, pre-menarchal or were
surgically steri1ized. 27 .
Legal Issues

In the case of Brown/eld vs. Daniel Freemand Marina Hospital [256 Cal. Rptr.
240 (cr. app. second distribution 1989)] a rape victim sued for declaratory and
injunctive relief because of the failure of a Catholic hospital where she was
treated to provide rape victims with information about and access to estrogen
pregnancy prophylaxis in the emergency room. The case was dismissed in the
trial court and the decision was upheld on appeal because the plaintiff had
claimed no damages as a result of the failure to provide information or access.
In dicta accompanying the decision, the court suggests that Catholic hospitals
might have a responsibility to "instruct the patient concerning options for
pregnancy prevention" or "to transfer the patient to another facility." No
hospital, obviously, is required to cooperate in abortion or to refer for abortion
given the protection of State and Federal conscience clauses.28 Catholic hospitals
can provide comprehensive services for rape victims through cooperation with
Catholic Social Services and consultants from the Catholic Physicians Guilds.
The evidence that "morning-after" pills are, in fact, abortifacient is
overwhelming and irrefutable.29,30,31,32 The use of postcoital hormonal agents is
not standard therapy after rape.33,34 There is no litigated case in which denial of
"morning-after" pills following rape has resulted in a greater risk of pregnancy.
Ethical Issues

It has been suggested by the British Bishops repoct4 that "morning after" pills .
may be given if there is a doubt as to whether ovulation has occurred. Us~g the .
principle of double effect, the "intention" of the person recommending the drug is
to prevent ovulation and not to prevent implantation. There are two problems
with this rationale. 1) There is formidable evidence that postcoital estrogens do
12
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not prevent ovulation3S and 2) aside from the 10% of Catholics and the 5% of the
general population using reliable methods of Natural Family Planning, there
would always be an irreconcilable doubt as to whether ovulation has occurred. 2
The choice then would seem to be between a medication which is either
ineffective or contraindicated. As the British Bishops state in their reply to
criticisms of their original statement "the upright and informed conscience will
not be willing to accept any substantial risk of killing the embryo."36
Other ethical issues have been summarized by Rohlfs37 as follows:
"Some will also defend the use of Ovral by the Principle of Double Effect. The
Principle of Double Effect cannot be used in the case of Ovral for several reasons.
First, it does not have two effects in a particular instance, but only one or the other
of two possible effects. As we have stated earlier, most of the time in a post-rape
situation Ovral will do nothing successful as either contraceptive or abortifacient.
But, if Ovral does anything successfully, it will be either as a contraceptive or as
an abortifacient. As we have seen, there does not seem to be any meaningful
contraceptive effect which Ovral could have by the time the woman presents
herself for post-rape treatment. As a result, if Ovral does anything meaningful
from a physiological standpoint, it would be as an abortifacient rather than as a
contraceptive in the post-rape context. Second, in the Principle of Double Effect
the good effect cannot be obtained in some equally expeditious and effective way
without the concomitant evil effect. This aspect of the Principle is clearly violated
in the case of the post-rape administration of Ovral since there is virtually no
chance of conception occurring in the first place. Thus, not administering Ovral is
just as effective as administering Ovral, since its de facto effect is that of a placebo.
Not administering Ovral is thus "equally expeditious and effective." Third, in the
Principle of Double Effect there must be due proportion between the good that is
intended and the evil that is permitted. In the calculation for this case, one could
hardly state that there is a due proportion exhibited between the possible
psychological solace of Ovral administered as a placebo and the possible
destruction of an innocent human life in an undetected pregnancy.
It is also common teaching that in a case where a fundamental human value
such as human life may be at stake, the safer course is always to be preferred. As
we have seen, in all likelihood the woman is not going to become pregnant in the
first place. Thus, what reasons could be given for taking any risk of an
abortifacient side effect by the administration of the Ovral treatment?
In conclusion, Directive 12 ofthe Ethical and Religious Directives states that,
"Every procedure whose sole immediate effect is the termination of pregnancy
before viability is an abortion which, in its moral context, includes the interval
between conception and implantation of the embryo." As indicated, it seems that
there is no meaningful contraceptive effect postcoital for Ovral or similar
treatments. By the time the woman presents herself for treatment, the "sole
immediate effect" of Ovral is to render the endometrium hostile to a possible
fertilized egg. This is the primary intention with which emergency room
physicians prescribe it and the primary intention with which women take it. It is a
simple fact that women and emergency room physicians are not usually
interested in purely contraceptive devices at this time, even if Ovral were in that
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category. It seems disingenuous for Catholic moralists to promote the Ovral
treatment for its reputed contraceptive effects when in fact doctors neither
prescribe nor do women take it for such purposes in the post-rape scenario.
In making our ethical analysis of the use of Ovral or similar treatments in
regards to post-rape scenario, we must take into consideration the possibility of
scandal given or scandal taken, or more likely, scandal given and taken. I have yet
to contact the non-Catholic physician who would not say that we are using a type
of mental gymnastics to maintain that Ovral is truly a contraceptive in a post-rape
protocol. If indeed Ovral has realistic contraceptive effects in such a scenario, it is
a well kept secret among Catholic physicians. Non-Catholic physicians seem to
find our "gnosis" quite bizarre. We do need to consider how those outside the
Church will look upon the distinctions that some are trying to make in regards to
Ovral. It does appear to many of them that this is nothing more than "loophole
theology" in which we appear to be trying to find a way to circumvent our own
ethical directives.
Summary

1) Catholic hospitals are required by law in many states to develop protocols
for the aftercare of rape.
2) Inclusion of "morning-after" pills in protocols has been justified by some
authorities for use in the instance of sexual assault in the pre-ovulatory phase of a
woman's cycle.
3) Whereas the abortifacient effect of postcoital estrogen or estrogenprogestogen administration is well established, the anti-ovulatory effect is highly
questionable.
4) The historical evidence provided by women as to their menstrual history is
not reliable when evaluated by objective hormone-assay controlled methods.
5) Given the logistics of the aftercare of rape victims in hospital emergency
room settings, it would not be possible to eliminate the significant probability that
postcoital hormone agents would be abortifacient in action.

1
.J..
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Appendix I
Proposed Supplementary Procedures to ACOG Protocol
for the Examination and Treatment of Victims of Sexual Assault

Time & Date of Examination:

Time & Date of Alleged Assault: _ _ _ _ _ __

Time elapsed since alleged assault:
Using contraception: Yes No

Date of LMP _ _ _ _ _ _ _ __
If yes, what _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

Speculum examination. (Obtain all samples required in rape protocol). Then perform postcoital test.
Is/ was conception possible or preventable?
spermatozoa present - viable or dead

no sperm seen
highly unlikely

Yes
Cervical mucus has fertile characteristics:
(estrogen effect) slippery, elastic, clear or cloudy.

no mucus, or sticky mucus
(progesterone effect)
no further pregnancy prevention treatment indicated,
only usual anti-STD Rx and counseling Rx indicated.

Obtain blood samples for LH, estrogen and
progesterone levels (tests results will not be available
in less than least 8 hours)
Perform vaginal ultrasound examination
to evaluate presence & size of dominant follicle.

,
~

If dominant follicle is seen (> 1.5 cm + in diameter,
consider transvaginal aspiration of the ovum from the
follicle under ultrasonic guidance. This requires
special skills and instruments - an IVF or GIFT
needle.

If no dominant follicle is seen, ovulation has passed,
or is not imminent.

If this is attempted by someone who is not a specialist
in egg retrieval and in vitro fertilization there is a
higher probability that the ovum will be spilled into
the peritoneal cavity and become accessible to
spermatozoa and conception [Since in vitro fertilization and related procedures are proscribed by Donum
Vitae it is not too likely that such specialists would be
found in Catholic hospitals.] As the ACOG Rape
Protocol estimates the risks of conception from rape
to be 2-4% of women who are not already on
contraception, counseling is indicated before attempting an egg removal! retrieval procedure. [The
additional expense of the vaginal ultrasound examination can be viewed in several ways: traditionally,
every procedure is expected to amortize the cost of the
equipment, but since vaginal ultrasound is used
regularly to diagnose, for instance, ectopic pregnancy,
it is already available.]

If there is no trained physician available, an
interventional radiologist can perform the procedure
transabdominally. This would not be done on an
emergency basis. Blood hormone levels would be
a vailable and helpful; on the other hand if ovulation
was imminent, it may have occurred in the interim.

Rx: counseling and anti-STD protocol.

Above algorithm provided by Hanna Klaus, M.D.
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Appendix D
Dr. Thomas Hilgers has proposed the following procedure as a research
project to evaluate a definitive program to prevent pregnancy after rape.
A.

Upon examining the rape victim, the physician studies the cervical
mucus for the presence or absence offerning. If the fern ofthe cervical
mucus is negative, then there is no need for any further evaluation or
treatment. If the ferning is positive, then it suggests that the cervix is
being stimulated by estrogen and ovulation is either approaching or is
just past. If the feming is positive, then the physician goes to step B.

B.

The patient with a positive fern then undergoes a pelvic ultrasound
examination looking for the presence of a follicle or a recently formed
corpus luteum. Also, the evaluation of the endometrium can be
undertaken to define whether or not the endometrium is proliferative or
secretory. In the presence of a follicle, the physician goes to step C.

C.

With step C, the patient is given a continuous infusion of Gonadotropin
Releasing Hormone (GnRH). With a continuous infusion of GnRH the
further development of the follicle should be stopped "in its tracks" and
ovulation will not occur.

D.

In the case where the ultrasound reveals the corpus luteum, no further
treatment would be necessary. It is possible, although very unlikely, that
a recently formed corpus luteum would reflect the possibility of
pregnancy. At the same time, the possibility does exist that it would
reflect an early postovulatory situation where pregnancy might occur
but only further evaluation would allow for that consideration to be
better defined.

E.

If the patient does become pregnant, then a pregnancy support program
should be available since studies and experience do suggest that these
patients do as well carrying the pregnancy as they do having had the
abortion.

The above research protocol deserves funding from sources such as the Catholic
Health Association or the NCCB as a means of resolving some of the
controversies.
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